Treatment of Muscle Cramps in Patients With Liver Cirrhosis

Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients

NCT05147090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Acamprosate Safe to Use in Individuals With Liver Disease.

NCT04287920 ·Status: COMPLETED ·Phase: PHASE2

Octreotide in Severe Polycystic Liver Disease

NCT00426153 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection

NCT00180674 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH

NCT04173065 ·Status: COMPLETED ·Phase: PHASE2

To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related Parkinsonism

NCT02265484 ·Status: COMPLETED ·Phase: NA

Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)

NCT00802555 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

NCT05327127 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis

NCT01220492 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of Long-term Peg Intron vs. Colchicine in Non-responders.

NCT00179413 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients

NCT02802228 ·Status: COMPLETED ·Phase: PHASE2

The Effect of Calcium β-hydroxy-β-methylbutyrate (CaHMB) Supplementation in Sarcopenia in Liver Cirrhosis

NCT03605147 ·Status: UNKNOWN ·Phase: NA

A Study of IDN-6556 in Subjects With Liver Cirrhosis

NCT02230670 ·Status: COMPLETED ·Phase: PHASE2

Antifibrotic Activity Of GI262570 In Chronic Hepatitis C Subjects

NCT00244751 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and Sarcopenia

NCT04874350 ·Status: COMPLETED ·Phase: PHASE2

Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients

NCT06863376 ·Status: RECRUITING ·Phase: PHASE2

Phase 2a Study of HPG1860 in Subjects With NASH

NCT05338034 ·Status: UNKNOWN ·Phase: PHASE2

A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of HSK21542 Injection in Liver Disease Subjects With Pruritus

NCT04999787 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study of hUC-MSCs Treating Decompensated Liver Cirrhosis With HBV

NCT05442437 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis

NCT03654053 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis

NCT00004748 ·Status: COMPLETED ·Phase: PHASE3

The Role of 5% Lidocaine Patches in the Pain Control of Hepatocellular Carcinoma Patients Receiving Radiofrequency Ablation

NCT05732181 ·Status: COMPLETED ·Phase: NA

Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT

NCT03283566 ·Status: COMPLETED ·Phase: PHASE2

Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis

NCT03517540 ·Status: COMPLETED ·Phase: PHASE2

Safety of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Decompensated Hepatitis B Cirrhosis

NCT05948982 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2